|
Volumn 27, Issue 1, 2007, Pages 89-90
|
Clozapine-associated restless legs syndrome [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
HALOPERIDOL;
LORAZEPAM;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
VALPROIC ACID;
ADD ON THERAPY;
ANAMNESIS;
BIPOLAR DISORDER;
BRADYKINESIA;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EXTRAPYRAMIDAL SYMPTOM;
FAMILY HISTORY;
HUMAN;
HYPERSALIVATION;
LABORATORY TEST;
LETTER;
MANIA;
NEUROLOGIC EXAMINATION;
PATHOGENESIS;
POLYSOMNOGRAPHY;
PRIORITY JOURNAL;
RECEPTOR OCCUPANCY;
RESTLESS LEGS SYNDROME;
SLEEP DISORDER;
TREMOR;
ADULT;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
CLOZAPINE;
HUMANS;
MALE;
RESTLESS LEGS SYNDROME;
|
EID: 33846258465
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e31802e7587 Document Type: Letter |
Times cited : (39)
|
References (9)
|